Indivior PLC Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$807.86 | Buy/Sell | $636.99 | 8.62% | 9 | $727.40B |
| MRK | Merck | Outperform |
2
|
$126.09 | Buy/Sell | $130.51 | 14.20% | 11 | $319.36B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.28 | Buy/Sell | £165.99 | 40.24% | 16 | £186.46B |
| PFE | Pfizer | Outperform |
2
|
$28.30 | Buy/Sell | $32.87 | 7.67% | 6 | $160.36B |
| SAN | Sanofi | Outperform |
16
|
88.58€ | Buy/Sell | 102.80€ | 23.05% | 9 | 110.74€B |
| ARGX | argenx | Outperform |
4
|
337.70€ | Buy/Sell | 531.81€ | 32.96% | 10 | 20.07€B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.76 | Buy/Sell | $11.59 | 1.43% | 9 | $18.98B |
| GMAB | Genmab A/S | Outperform |
16
|
kr1.93k | Buy/Sell | kr2.71k | 35.95% | 14 | kr124.74B |
| VTRS | Viatris Inc | Hold |
8
|
$10.39 | Buy/Sell | $11.73 | 15.50% | 5 | $13.32B |
| REC | Recordati Industria Chimica e ... | Hold |
18
|
48.10€ | Buy/Sell | 48.61€ | 6.96% | 1 | 10.36€B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$65.62 | Buy/Sell | $79.10 | 37.92% | 10 | $6.86B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.05 | Buy/Sell | £28.11 | 53.33% | 9 | £4.42B |
| ZEAL | Zealand Pharma A/S | Buy |
8
|
kr614.50 | Buy/Sell | kr357.00 | 32.63% | 2 | kr38.52B |
| ORNBV | Orion Oyj | Hold |
14
|
37.01€ | Buy/Sell | 42.52€ | 13.48% | 3 | 5.12€B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr37.14 | Buy/Sell | kr190.00 | 5.01% | 6 | kr36.60B |
| ALK B | ALK-Abelló A/S | Outperform |
13
|
kr153.10 | Buy/Sell | kr109.25 | 7.77% | 3 | kr33.91B |
| ALKS | Alkermes | Outperform |
10
|
$23.75 | Buy/Sell | $33.27 | 34.74% | 3 | $4.11B |
| MOR | MorphoSys | Hold |
6
|
67.85€ | Buy/Sell | 28.78€ | 0.22% | 3 | 2.52€B |
| 1795 | Lotus Pharmaceutical | Buy |
16
|
NT$280.50 | Buy/Sell | NT$339.40 | 22.64% | 4 | NT$74.71B |
| ALM | Almirall | Outperform |
16
|
9.83€ | Buy/Sell | 11.39€ | 11.90% | 3 | 1.94€B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.79 | Buy/Sell | $6.13 | 17.82% | 1 | $2.09B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$41.98 | Buy/Sell | $69.00 | 47.69% | 0 | $2.09B |
| EVT | Evotec | Outperform |
14
|
9.04€ | Buy/Sell | 37.33€ | 76.99% | 4 | 1.70€B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF71.20 | Buy/Sell | CHF76.55 | 31.40% | 0 | CHF1.14B |
| FAE | Faes Farma | Hold |
18
|
3.73€ | Buy/Sell | 3.90€ | -2.14% | 0 | 1.09€B |
| PHM | Pharma Mar | Outperform |
13
|
36.98€ | Buy/Sell | 50.20€ | 29.80% | 1 | 536.95€M |
| BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | Buy/Sell | $10.00 | 16.46% | 0 | $577.05M |
| BSLN | Basilea Pharmaceutica | Outperform |
6
|
CHF43.45 | Buy/Sell | CHF65.63 | 51.90% | 0 | CHF522.10M |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$4.98 | Buy/Sell | $4.25 | 4.62% | 0 | $311.94M |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.10 | Buy/Sell | $6.33 | 190.32% | 0 | $307.71M |
| DBV | DBV Technologies | Outperform |
5
|
1.22€ | Buy/Sell | 4.07€ | 227.87% | 1 | 115.65€M |
| MOLN | Molecular Partners | Outperform |
4
|
CHF3.36 | Buy/Sell | CHF9.50 | 178.27% | 1 | CHF110.77M |
| ORX | Orexo AB (publ) |
6
|
kr21.25 | Buy/Sell | kr25.50 | 12.94% | 0 | kr661.43M | |
| TTNP | Titan Pharmaceuticals | - |
0
|
$6.80 | Buy/Sell | $7.00 | -100.00% | 0 | $5.61M |